First-Steps With Time-Limited BTKi-B–cell lymphoma 2 Inhibitor Options in Treatment Naïve CLL - report from EHA2025

Medical Digest & Congress Report
23/06/2025 6 min

Listen "First-Steps With Time-Limited BTKi-B–cell lymphoma 2 Inhibitor Options in Treatment Naïve CLL - report from EHA2025"

Descargar episodio Ver en sitio original

Episode Synopsis

Professor Lydia Scarfò shares her insights on BTKi-B–cell lymphoma 2 inhibitor options in treatment naïve CLL at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:first-steps-time-limited-btki-bcell-lymphoma-2-inhibitor-options-treatment-naive-cll

More episodes of the podcast Medical Digest & Congress Report

Immuno-oncology biomarkers in locally advanced HNSCC - lessons from the KeyNote-689 trial - report from ESMO 2025 14/11/2025
Novelties of the treatment of colon cancer at ESMO 2025 14/11/2025
How to PROC - Breaking the Wall of Platinum-Resistance in Ovarian Cancer - report from ESMO 2025 14/11/2025
IMvigor011: A Phase 3 Trial of ctDNA-Guided Adjuvant Atezolizumab versus Placebo in MIBC - report from ESMO 2025 14/11/2025
T-DXd Effective for Treating HER2+ Advanced or Metastatic Breast Cancer, Regardless of Treatment History, HR Status, or PIK3C Mutations - report from ESMO 2025 14/11/2025
What's new in ESMO guidelines? - report from ESMO 2025 14/11/2025
DYNAMIC-III trial results: ctDNA blood test is a powerful tool to guide treatment choices for people with advanced colon cancer - report from ESMO 2025 13/11/2025
Overcoming Therapeutic Challenges in High-risk Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Approach - report from ESMO 2025 13/11/2025
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials - report from ESMO 2025 13/11/2025
Durvalumab in Combination with BCG for BCG-Naïve High-Risk NMIBC: Final Analysis of the Phase 3, Open-Label, Randomized POTOMAC Trial - report from ESMO 2025 13/11/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA